Effects of caveolin-1 deficiency on palmitic acid-induced apoptosis of islet-β cells
Kunying Liu, Wen Zeng, Shuo Lin, Chuwen Lin, Hangya Peng, Haicheng Li, Longyi Zeng
Abstract
Kunying Liu, Wen Zeng, Shuo Lin, Chuwen Lin, Hangya Peng, Haicheng Li, Longyi Zeng
Abstract
Objective To investigate the role of caveolin-1 (Cav1) in palmitic acid-induced survival of pancreatic islet β-cell. Methods Cav1-deficient NIT-1 cells and mouse primary islets were constructed through lentiviral vector transfection. Control-shRNA was transfected as a control. After fatty-acid-free bovine serum albumin (BSA) and palmitic acid (0.5 mmol/L) incubation for 24 and 48 hours, cell viability and apoptosis werecalculated by methylcyclopentadienyl manganese tricarbonylassay and Hoechst33342/propidium iodide (PI) double staining.Real time PCR and Western blot were used to detect the expression of apoptosis-associated mRNA and protein. The t test and one-way ANOVA were used for statistical analysis. Results Compared with the control group, the cell survival rate of the palmitic acid treatment group was significantly decreased (0.89±0.10 vs 0.24±0.04, t=13.49, P<0.01), and mRNA and protein expressions of P18 and P19 were up-regulated (1.00±0.09 vs 1.30±0.04, 1.00±0.04 vs 1.37±0.13, t=5.28, 4.71, both P<0.05; 0.87±0.04, 1.48±0.05, 1.02±0.06 vs 1.41±0.07, t=16.50, 7.33, both P<0.01); mRNA expression levels of cysteine-containing aspartic proteolytic enzymes (Caspase-6, Caspase-9, and Caspase-12) were significantly up-regulated (1.00±0.04 vs 1.57±0.08, 1.01±0.15 vs 1.57±0.20, 1.02±0.19 vs 1.57±0.09, t=11.04,3.88, 4.53, all P<0.05), and protein expression of them were also significantly increased (0.86±0.10 vs 1.28±0.11, 0.69±0.01 vs 0.86±0.06, 0.70±0.02 vs 1.18±0.01, t=4.89,4.84, 37.18, all P<0.01). The cell survival rate of Cav1-shRNA+palmitic acid group was significantly higher than that of Ctrl-shRNA+palmitic acid group (0.53±0.10 vs 0.26±0.08, t=4.71, P<0.01). The mRNA and protein expression of P19 were all down-regulated (1.53±0.18 vs 0.66±0.04, 1.48±0.05 vs 0.70±0.02, t=8.17, 25.09, both P<0.01); mRNA expression levels of Caspase-6, Caspase-7, Caspase-9 and Caspase-12 were down-regulated (1.82±0.11 vs 1.03±0.07, 1.43±0.24 vs 0.42±0.15, 1.41±0.22 vs 0.51±0.18, 1.45±0.18 vs 0.42±0.13, t=5.48-10.49, all P<0.01), and protein expression of them were also down-regulated (0.99±0.14 vs 0.63±0.11, 0.90±0.14 vs 0.62±0.04, 0.90±0.02 vs 0.60±0.04, 1.30±0.01 vs 0.65±0.04, t=3.50-27.31, all P<0.01). Conclusion Cav1 deficiency inhibites palmitic acid-induced pancreatic β-cell apoptosis via regulating Caspase family, and ultimately protects β cell viability. Key words: Caveolin 1; Apoptosis; Cell proliferation; Islet-β cells
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the role of caveolin-1 (Cav1) in palmitic acid-induced survival of pancreatic islet β-cell. Methods Cav1-deficient NIT-1 cells and mouse primary islets were constructed through lentiviral vector transfection. Control-shRNA was transfected as a control. After fatty-acid-free bovine serum albumin (BSA) and palmitic acid (0.5 mmol/L) incubation for 24 and 48 hours, cell viability and apoptosis werecalculated by methylcyclopentadienyl manganese tricarbonylassay and Hoechst33342/propidium iodide (PI) double staining.Real time PCR and Western blot were used to detect the expression of apoptosis-associated mRNA and protein. The t test and one-way ANOVA were used for statistical analysis. Results Compared with the control group, the cell survival rate of the palmitic acid treatment group was significantly decreased (0.89±0.10 vs 0.24±0.04, t=13.49, P<0.01), and mRNA and protein expressions of P18 and P19 were up-regulated (1.00±0.09 vs 1.30±0.04, 1.00±0.04 vs 1.37±0.13, t=5.28, 4.71, both P<0.05; 0.87±0.04, 1.48±0.05, 1.02±0.06 vs 1.41±0.07, t=16.50, 7.33, both P<0.01); mRNA expression levels of cysteine-containing aspartic proteolytic enzymes (Caspase-6, Caspase-9, and Caspase-12) were significantly up-regulated (1.00±0.04 vs 1.57±0.08, 1.01±0.15 vs 1.57±0.20, 1.02±0.19 vs 1.57±0.09, t=11.04,3.88, 4.53, all P<0.05), and protein expression of them were also significantly increased (0.86±0.10 vs 1.28±0.11, 0.69±0.01 vs 0.86±0.06, 0.70±0.02 vs 1.18±0.01, t=4.89,4.84, 37.18, all P<0.01). The cell survival rate of Cav1-shRNA+palmitic acid group was significantly higher than that of Ctrl-shRNA+palmitic acid group (0.53±0.10 vs 0.26±0.08, t=4.71, P<0.01). The mRNA and protein expression of P19 were all down-regulated (1.53±0.18 vs 0.66±0.04, 1.48±0.05 vs 0.70±0.02, t=8.17, 25.09, both P<0.01); mRNA expression levels of Caspase-6, Caspase-7, Caspase-9 and Caspase-12 were down-regulated (1.82±0.11 vs 1.03±0.07, 1.43±0.24 vs 0.42±0.15, 1.41±0.22 vs 0.51±0.18, 1.45±0.18 vs 0.42±0.13, t=5.48-10.49, all P<0.01), and protein expression of them were also down-regulated (0.99±0.14 vs 0.63±0.11, 0.90±0.14 vs 0.62±0.04, 0.90±0.02 vs 0.60±0.04, 1.30±0.01 vs 0.65±0.04, t=3.50-27.31, all P<0.01). Conclusion Cav1 deficiency inhibites palmitic acid-induced pancreatic β-cell apoptosis via regulating Caspase family, and ultimately protects β cell viability. Key words: Caveolin 1; Apoptosis; Cell proliferation; Islet-β cells
Key concepts: Propidium iodide, Palmitic acid, Apoptosis, Molecular biology, Transfection, Western blot, Viability assay, Chemistry